The long-term cost-effectiveness of improving alcohol abstinence with adjuvant acamprosate

Alcohol and Alcoholism

Volumn 35, Issue 5, 2000, Pages 478-492

  Palmer, A J ^a,d   Neeser, K ^a   Weiss, C ^a   Brandt, A ^a   Comte, S ^b   Fox, M ^c  

^a IMIB   (Switzerland)

^b Service De Physiopathologie Animale   (France)

^c KENT AND SUSSEX HOSPITAL   (United Kingdom)

^d NONE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE;

ACCIDENTAL DEATH; ACUTE PANCREATITIS; ADJUVANT THERAPY; ALCOHOL ABSTINENCE; ALCOHOL LIVER DISEASE; ALCOHOL PSYCHOSIS; ALCOHOLIC CARDIOMYOPATHY; ALCOHOLISM; ARTICLE; CHRONIC PANCREATITIS; COMPUTER MODEL; COST EFFECTIVENESS ANALYSIS; ESOPHAGUS CARCINOMA; GASTRITIS; GERMANY; HUMAN; LIFE EXPECTANCY; OROPHARYNX CARCINOMA; PATIENT COUNSELING; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROBABILITY; RELAPSE; SUICIDE;

EID: 0033774361     PISSN: 07350414     EISSN: None     Source Type: Journal    
DOI: 10.1093/alcalc/35.5.478     Document Type: Article

References (107)

1. Regression of severe alcoholic cardiomyopathy after abstinence of 10 weeks
2. Influence of alcohol consumption on the initial development of chronic pancreatitis
3. A cross-national trial of brief interventions with heavy drinkers. WHO Brief Intervention Study Group
4. Reversibility of alcoholic cardiomyopathy with abstention from alcohol
5. Prediction of risk of liver disease by alcohol intake, sex, and age: A prospective population study
6. The influence of alcohol drinking and alcohol use disorders on psychiatric disorders and suicidal behavior
7. Efficacy of liver transplantation for alcoholic cirrhosis with respect to recidivism and compliance
8. Alcoholism - The cost of illness in the Federal Republic of Germany
9. Incidence of large oesophageal varices in patients with cirrhosis: Application to prophylaxis of first bleeding
10. Attempted suicide and alcohol dependence: Results of an epidemiological survey
11. Effectiveness of brief intervention on non-dependent alcohol drinkers (EBIAL): A Spanish multi-centre study
12. The natural course of alcoholic cardiomyopathy
13. Psychiatric co-morbidity, suicidal behavior and suicidal ideation in alcoholics seeking treatment
14. Brief intervention after alcohol-related injuries
15. Outcome studies of brief alcohol intervention in general practice: The problem of lost subjects
16. Olita: An alternative in the treatment of therapy-resistant chronic alcoholics. First evaluation of a new approach
17. Significance of type II fiber atrophy in chronic alcoholic myopathy
18. Acamprosate and prevention of relapse in alcoholics
19. Experimentelle methoden in der hepatologie. Richtlinien der Deutschen Arbeitsgemeinschaft zum Studium der Leber (GASL). Aszitestherapie bei Lebererkrankungen
20. Alcohol use following liver transplantation for alcoholic cirrhosis
21. The mortality rate and causes of death of treated chronic alcoholics
22. Epidemiology of alcoholic liver disease
23. Population based cohort study of the association between alcohol intake and cancer of the upper digestive tract
24. Effect of alcohol consumption on variceal rebleeding and mortality
25. Alcohol screening and brief intervention: Where research meets practice
26. The reduction of health care costs associated with alcoholism treatment: A 14-year longitudinal study
27. The economic benefits of alcoholism treatment: A summary of twenty years of research
28. Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials
29. Effects of abstinence on alcoholic heart muscle disease
30. The fate of untreated alcoholics
31. Suicide in alcoholics
32. Orthotopic liver transplantation for alcoholic liver disease
33. Etiology of human liver cancer: Controlled prospective study in liver cirrhosis
34. Cirrhosis in the alcoholic and its relation to the volume of alcohol abuse
35. Chronischer alkoholismus-alkoholfolgekrankheiten-todesursachen
36. Screening and brief intervention for high-risk college student drinkers: Results from a 2-year follow-up assessment
37. A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence
38. Some guidelines on the use of cost-effectiveness league tables
39. The effects of alcohol use on rebleeding and mortality in patients with alcoholic cirrhosis following variceal haemorrhage
40. Reducing alcohol consumption. Comparing three brief methods in family practice
41. Role of tobacco and alcoholic beverages in the etiology of cancer of the oral cavity/oropharynx in Torino, Italy
42. Improvement of left ventricular function in chronic alcoholics following abstinence from ethanol
43. Autonomic and peripheral neuropathies in patients with chronic alcoholism. A dose-related toxic effect of alcohol
44. Naltrexone in the treatment of alcoholism: A clinical review
45. Naltrexone and coping skills therapy for alcohol dependence. A controlled study
46. Six-month follow-up of naltrexone and psychotherapy for alcohol dependence
47. Experience of a 'slip' among alcoholics treated with naltrexone or placebo
48. Okonomische analyse der sekundarpravention der koronaren herzkrankheit mit simvastatin (Zocor) in Deutschland
49. Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol
50. Contribution of acamprosate in maintaining abstinence in weaned alcohol-dependent patients: Additional results of the second French multicentre study
51. Peripheral nerve functions in chronic alcoholic patients on disulfiram: A six month follow up
52. The impact of three different management strategies on the development of diabetic nephropathy: A cost-effectiveness analysis for Germany
53. Cost-effectiveness of intensive therapy for type I diabetes changes depending on risk factors and level of existing complications
54. The cost-effectiveness of different management strategies for type 1 diabetes: A Swiss perspective
55. Acute pancreatic injury in asymptomatic individuals after heavy drinking over the long-term
56. Normalization of variables of left ventricular function in patients with alcoholic cardiomyopathy after cessation of excessive alcohol intake: An echocardiographic study
57. Acamprosate in the treatment of alcohol dependence: A six month post-detoxification study
58. Efficacy and safety of acamprosate in the treatment of detoxified alcohol-dependent patients, a 90-day placebo-controlled dose-finding study
59. A five-year mortality study of alcoholics
60. Ascitic cirrhosis in relation to alcohol consumption
61. Peripheral neuropathy in liver cirrhosis. A clinical and electrophysiological study
62. Hepatozellulares karzinom in Deutschland. Epidemiologie, atiologie, klinik und prognose bei 100 konsekutiven patienten einer Universitatsklinik
63. First-time admissions with alcohol-related medical problems: A 10-year follow-up of a national sample of alcoholic patients
64. Acamprosate treatment in a long-term community-based alcohol rehabilitation programme
65. Differences of disease progression in congestive heart failure due to alcoholic as compared to idiopathic dilated cardiomyopathy
66. Alcoholic cardiomyopathy
67. Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence
68. Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence
69. Epidemiology of alcoholic liver disease
70. The cost effectiveness of acamprosate in the treatment of alcoholism in Germany
71. Kosten/nutzen-relation der herztransplantation
72. Severe alcoholic cardiomyopathy reversed with abstention from alcohol
73. Brief intervention in a primary care setting for hazardous drinkers
74. Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine
75. Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis
76. Primary hepatic cancer in alcoholics
77. Patterns of alcohol consumption after liver transplantation
78. Primary prophylaxis of variceal bleeding in cirrhosis: A cost-effectiveness analysis
79. Prevention of recurrent esophageal bleeding and survival in patients with alcoholic cirrhosis: A randomized study
80. Naltrexone in the treatment of alcohol dependence
81. Naltrexone in the treatment of alcoholism: Predicting response to naltrexone
82. Effect of naltrexone on alcohol 'high' in alcoholics
83. Naltrexone and alcohol dependence. Role of subject compliance
84. Evolution et pronostic des cardiomyopathies congestives d'apparence primitive chez les sujets ethyliques chroniques
85. Recommendations of the Panel on Cost-effectiveness in Health and Medicine
86. Estimating treatment benefits for the elderly: The effect of competing risks
87. Zur Ruckbildungsfahigkeit vegetativer symptome bei der alkoholischen polyneuropathie
88. Comparison of acamprosate and placebo in long-term treatment of alcohol dependence
89. Meta-analysis of randomized control trials addressing brief interventions in heavy alcohol drinkers
90. Gains in life expectancy from medical interventions - Standardizing data on outcomes
91. Intervention by an alcohol health worker in an accident and emergency department